Analysis of Aflibercept Expression in NHPs following Intravitreal Administration of ADVM-022, a Potential Gene Therapy for nAMD

por Kiss, Szilárd, Grishanin, Ruslan, Nguyen, Aivan, Rosario, Romeo, Greengard, Judith S., Nieves, Julio, Gelfman, Claire M., Gasmi, Mehdi
Publicado 2020

Comprehensive Preclinical Assessment of ADVM-022, an Intravitreal Anti-VEGF Gene Therapy for the Treatment of Neovascular AMD and Diabetic Macular Edema

por Gelfman, Claire M., Grishanin, Ruslan, Bender, Kristina Oresic, Nguyen, Aivan, Greengard, Judith, Sharma, Pallavi, Nieves, Julio, Kiss, Szilárd, Gasmi, Mehdi
Publicado 2021

Preclinical Evaluation of ADVM-022, a Novel Gene Therapy Approach to Treating Wet Age-Related Macular Degeneration

por Grishanin, Ruslan, Vuillemenot, Brian, Sharma, Pallavi, Keravala, Annahita, Greengard, Judith, Gelfman, Claire, Blumenkrantz, Mark, Lawrence, Matthew, Hu, Wenzheng, Kiss, Szilárd, Gasmi, Mehdi
Publicado 2019

Long-Term Safety Evaluation of Continuous Intraocular Delivery of Aflibercept by the Intravitreal Gene Therapy Candidate ADVM-022 in Nonhuman Primates

por Kiss, Szilárd, Oresic Bender, Kristina, Grishanin, Ruslan N., Hanna, Kelly M., Nieves, Julio D., Sharma, Pallavi, Nguyen, Aivan T., Rosario, Romeo J., Greengard, Judith S., Gelfman, Claire M., Gasmi, Mehdi
Publicado 2021